Top Markets
#1 MowCat MowCat +48.92%
#2 Velvet Velvet +38.78%
#3 Quack AI Quack AI +21.60%
#4 Derive Derive +18.03%
#5 Bermuda Shorts Bermuda Shorts +15.19%
#6 Audiera Audiera +14.78%
#7 aPriori aPriori +12.52%
#8 SkyAI SkyAI +12.41%
#9 Biconomy Biconomy +12.29%
#10 Cross Cross +11.36%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
Rank in Stocks #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
Share Price
$1.85
Last synced: 2024-08-19
Market Cap
$3.96M
Change (1 day)
2.78%
Change (1 year)
0.00%
Country
US
Trade MyMD Pharmaceuticals, Inc. (MYMD)

Category

Healthcare
EPS for MyMD Pharmaceuticals, Inc. (MYMD)
EPS as of 2026 TTM: 0
According to MyMD Pharmaceuticals, Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for MyMD Pharmaceuticals, Inc. from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE